HAPTOGLOBIN DECREASED side effect
What is HAPTOGLOBIN DECREASED ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
HAPTOGLOBIN DECREASED and Recently Reported Side Effects
HAPTOGLOBIN DECREASED and 15 most Active Side Effect polls
HAPTOGLOBIN DECREASED and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with HAPTOGLOBIN DECREASED
AVASTIN BUSULFAN CICLOSPORIN CYCLOSPORINE LAPATINIB NEORAL SANDIMMUNE TAXOTERE WINRHO ZELITREXAvastin Side Effects Report #5351563-3
Health Professional from UNITED KINGDOM reported AVASTIN problem on May 25, 2007. Male patient, 70 years of age, weighting 185.2 lb, was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: haptoglobin decreased, thrombocytopenia, . AVASTIN dosage: 800 MG, 2/MONTH. During the same period patient was treated with INTRON A. Patient was hospitalized. Patient recovered.
Lapatinib Side Effects Report #5757056-3
LAPATINIB problem was reported by a Physician from BELGIUM on May 28, 2008. Female patient, 38 years of age, weighting 149.9 lb, was diagnosed with pain prophylaxis, urinary tract infection and was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia, haptoglobin decreased, hyperbilirubinaemia, ocular icterus, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with XELODA, IMODIUM, OMEPRAZOLE, CIPROFLOXACIN. Patient recovered.
Neoral Side Effects Report #5763622-1
Physician from JAPAN reported NEORAL problem on May 26, 2008. Male patient, child 5 years of age, was diagnosed with aplastic anaemia and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia, haptoglobin decreased, . NEORAL dosage: 6 MG/KG/DAY. Patient was hospitalized. Patient recovered.
Lapatinib Side Effects Report #5787924-8
LAPATINIB problem was reported by a Physician from BELGIUM on June 17, 2008. Female patient, 38 years of age, weighting 149.9 lb, was diagnosed with pain prophylaxis, urinary tract infection and was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia, haptoglobin decreased, hyperbilirubinaemia, ocular icterus, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE, IMODIUM, OMEPRAZOLE, CIPROFLOXACIN. Patient recovered.
Sandimmune Side Effects Report #5727780-7
Physician from JAPAN reported SANDIMMUNE problem on Apr 22, 2008. Male patient, child 4 years of age, was diagnosed with aplastic anaemia and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia, haptoglobin decreased, . SANDIMMUNE dosage: 6 MG/ KG/ DAY. Patient recovered.
Sandimmune Side Effects Report #5721659-2
SANDIMMUNE problem was reported by a Physician from JAPAN on Apr 22, 2008. Male patient, child 4 years of age, was diagnosed with aplastic anaemia and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia, haptoglobin decreased, . SANDIMMUNE dosage: 6 MG/ KG/ DAY. Patient recovered.
Sandimmune Side Effects Report #5723434-1
Physician from JAPAN reported SANDIMMUNE problem on Apr 22, 2008. Male patient, child 4 years of age, was diagnosed with aplastic anaemia and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia, haptoglobin decreased, . SANDIMMUNE dosage: 6 MG/ KG/ DAY. Patient recovered.
Winrho Side Effects Report #5291770-1
WINRHO problem was reported by a Physician from UNITED STATES on Apr 06, 2007. Female patient, 68 years of age, weighting 219.0 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with WINRHO. After drug was administered, patient experienced the following problems/side effects: haemoglobinuria, haptoglobin decreased, hyperbilirubinaemia, hypotension, hypoxia, infusion related reaction, intravascular haemolysis, renal failure acute, . WINRHO dosage: unknown. Patient was hospitalized. Patient recovered.
Zelitrex Side Effects Report #5584288-X
Consumer or non-health professional from FRANCE reported ZELITREX problem on Dec 31, 2007. Male patient, child 12 years of age, was treated with ZELITREX. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, haemolytic anaemia, haptoglobin decreased, . ZELITREX dosage: 500MG TWICE PER DAY. During the same period patient was treated with ORACILLIN, FUNGIZONE, GARDENAL. Patient was hospitalized. Patient recovered.
Taxotere Side Effects Report #5598364-9
TAXOTERE problem was reported by a Consumer or non-health professional from on Jan 14, 2008. Female patient, 69 years of age, weighting 154.3 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, haemolytic anaemia, haptoglobin decreased, oedema, rash, . TAXOTERE dosage: unknown. During the same period patient was treated with DIFFU K, NEORECORMON. Patient was hospitalized. Patient recovered.
Ciclosporin Side Effects Report #5482111-5
Consumer or non-health professional from JAPAN reported CICLOSPORIN problem on Oct 03, 2007. Female patient, 46 years of age, was treated with CICLOSPORIN. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, focal glomerulosclerosis, haptoglobin decreased, proteinuria, red blood cell abnormality, thrombotic microangiopathy, . CICLOSPORIN dosage: unknown. Patient recovered.
Cyclosporine Side Effects Report #5487667-4
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on Oct 10, 2007. Female patient, 46 years of age, was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, focal glomerulosclerosis, haptoglobin decreased, proteinuria, red blood cell abnormality, thrombotic microangiopathy, . CYCLOSPORINE dosage: unknown. Patient recovered.
Busulfan Side Effects Report #5468657-4
Health Professional from JAPAN reported BUSULFAN problem on Sept 11, 2007. Female patient, 30 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, haptoglobin decreased, platelet count decreased, red blood cell schistocytes present, thrombotic microangiopathy, . BUSULFAN dosage: 26.12 ML;QD;IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NEUPOGEN, METHOTREXATE, CICLOSPORIN. Patient died.